The India Cements Limited has informed the Exchange about Transcript
INDIACEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
India Cements (now an UltraTech subsidiary) submitted the Q4 FY25 earnings call transcript of UltraTech Cement held on April 28, 2025. UltraTech reported ~10% volume growth versus ~4% industry growth, with total capacity rising to 184 million tons after absorbing Kesoram and India Cements assets. India Cements hit EBITDA breakeven in its first quarter under UltraTech, with guidance of INR500/ton EBITDA this year, INR800/ton by FY27, and a 4-digit mark thereafter. A capex plan of INR1,500 crores is earmarked for India Cements, including INR1,000 crores for WHRS and efficiency upgrades with payback under 3 years. UltraTech's like-for-like EBITDA per ton stood at INR1,270 in Q4, with net debt-to-EBITDA at 1.16x and a long-term target of 0.5x. FY26 capex is guided at INR9,000-10,000 crores to lift capacity to ~212 million tons.
Strong margin expansion roadmap for acquired assets and double-digit FY26 volume growth guidance are positive signals. Deleveraging commitment to 0.5x net debt/EBITDA supports balance sheet strength, though short-term volumes are weak due to the ongoing heat wave, and India Cements will be rebranded under UltraTech by end of FY27.